Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?

Breast cancer research : BCR ·第 14 卷 ·第 6 期 ·2015-06-25

Turner Nicholas C, Tutt Andrew N J

摘要

A recent prospective clinical trial provides further evidence that breast cancers arising in germline BRCA1 mutation carriers are highly sensitive to cisplatin chemotherapy. The potential significance of these data for the management of patients with BRCA1-related and BRCA2-related breast cancer is discussed.

文献信息

期刊

Breast cancer research : BCR

期刊简称

Breast Cancer Res

ISSN

1465-5411

发表日期

2015-06-25

收录日期

2014-07-02

更新日期

2016-12-06

语言

英语

国家/地区

England

NLM ID

100927353

外部链接

PubMed 原文查看期刊详情

分析服务

Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?

联系地址

微信公众号